For months, biotech companies and government officials talked about eventually needing a coronavirus booster vaccine. Now that the Delta variant accounts for 98.8% of new U.S. infections, the possibility of wheeling out a booster is more real. Moderna stock (NASDAQ: MRNA) got a huge pop since rolling out its initial vaccines. It's up 466%% year-over-year. Now, investors hope another round of vaccine distributions may fuel the company's bottom line and translate to similar gains. They could be right... Read more... Tags: Stocks to Buy The post Why Moderna Stock Is Still a Strong Buy Now appeared first on Money Morning - We Make Investing Profitable .